Cargando…
Curcumin Diglutaric Acid, a Prodrug of Curcumin Reduces Pain Hypersensitivity in Chronic Constriction Injury of Sciatic Nerve Induced-Neuropathy in Mice
The drug treatment for neuropathic pain remains a challenge due to poor efficacy and patient satisfaction. Curcumin has been reported to alleviate neuropathic pain, but its clinical application is hindered by its low solubility and poor oral bioavailability. Curcumin diglutaric acid (CurDG) is a cur...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558758/ https://www.ncbi.nlm.nih.gov/pubmed/32867013 http://dx.doi.org/10.3390/ph13090212 |
_version_ | 1783594710015672320 |
---|---|
author | Limcharoen, Thanchanok Dasuni Wasana, Peththa Wadu , Hasriadi Muangnoi, Chawanphat Vajragupta, Opa Rojsitthisak, Pornchai Towiwat, Pasarapa |
author_facet | Limcharoen, Thanchanok Dasuni Wasana, Peththa Wadu , Hasriadi Muangnoi, Chawanphat Vajragupta, Opa Rojsitthisak, Pornchai Towiwat, Pasarapa |
author_sort | Limcharoen, Thanchanok |
collection | PubMed |
description | The drug treatment for neuropathic pain remains a challenge due to poor efficacy and patient satisfaction. Curcumin has been reported to alleviate neuropathic pain, but its clinical application is hindered by its low solubility and poor oral bioavailability. Curcumin diglutaric acid (CurDG) is a curcumin prodrug with improved water solubility and in vivo antinociceptive effects. In this study, we investigated the anti-inflammatory mechanisms underlying the analgesic effect of CurDG in the chronic constriction injury (CCI)-induced neuropathy mouse model. Repeated oral administration of CurDG at a low dose equivalent to 25 mg/kg/day produced a significant analgesic effect in this model, both anti-allodynic activity and anti-hyperalgesic activity appearing at day 3 and persisting until day 14 post-CCI surgery (p < 0.001) while having no significant effect on the motor performance. Moreover, the repeated administration of CurDG diminished the increased levels of the pro-inflammatory cytokines: TNF-α and IL-6 in the sciatic nerve and the spinal cord at the lowest tested dose (equimolar to 25 mg/kg curcumin). This study provided pre-clinical evidence to substantiate the potential of pursuing the development of CurDG as an analgesic agent for the treatment of neuropathic pain. |
format | Online Article Text |
id | pubmed-7558758 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75587582020-10-26 Curcumin Diglutaric Acid, a Prodrug of Curcumin Reduces Pain Hypersensitivity in Chronic Constriction Injury of Sciatic Nerve Induced-Neuropathy in Mice Limcharoen, Thanchanok Dasuni Wasana, Peththa Wadu , Hasriadi Muangnoi, Chawanphat Vajragupta, Opa Rojsitthisak, Pornchai Towiwat, Pasarapa Pharmaceuticals (Basel) Article The drug treatment for neuropathic pain remains a challenge due to poor efficacy and patient satisfaction. Curcumin has been reported to alleviate neuropathic pain, but its clinical application is hindered by its low solubility and poor oral bioavailability. Curcumin diglutaric acid (CurDG) is a curcumin prodrug with improved water solubility and in vivo antinociceptive effects. In this study, we investigated the anti-inflammatory mechanisms underlying the analgesic effect of CurDG in the chronic constriction injury (CCI)-induced neuropathy mouse model. Repeated oral administration of CurDG at a low dose equivalent to 25 mg/kg/day produced a significant analgesic effect in this model, both anti-allodynic activity and anti-hyperalgesic activity appearing at day 3 and persisting until day 14 post-CCI surgery (p < 0.001) while having no significant effect on the motor performance. Moreover, the repeated administration of CurDG diminished the increased levels of the pro-inflammatory cytokines: TNF-α and IL-6 in the sciatic nerve and the spinal cord at the lowest tested dose (equimolar to 25 mg/kg curcumin). This study provided pre-clinical evidence to substantiate the potential of pursuing the development of CurDG as an analgesic agent for the treatment of neuropathic pain. MDPI 2020-08-27 /pmc/articles/PMC7558758/ /pubmed/32867013 http://dx.doi.org/10.3390/ph13090212 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Limcharoen, Thanchanok Dasuni Wasana, Peththa Wadu , Hasriadi Muangnoi, Chawanphat Vajragupta, Opa Rojsitthisak, Pornchai Towiwat, Pasarapa Curcumin Diglutaric Acid, a Prodrug of Curcumin Reduces Pain Hypersensitivity in Chronic Constriction Injury of Sciatic Nerve Induced-Neuropathy in Mice |
title | Curcumin Diglutaric Acid, a Prodrug of Curcumin Reduces Pain Hypersensitivity in Chronic Constriction Injury of Sciatic Nerve Induced-Neuropathy in Mice |
title_full | Curcumin Diglutaric Acid, a Prodrug of Curcumin Reduces Pain Hypersensitivity in Chronic Constriction Injury of Sciatic Nerve Induced-Neuropathy in Mice |
title_fullStr | Curcumin Diglutaric Acid, a Prodrug of Curcumin Reduces Pain Hypersensitivity in Chronic Constriction Injury of Sciatic Nerve Induced-Neuropathy in Mice |
title_full_unstemmed | Curcumin Diglutaric Acid, a Prodrug of Curcumin Reduces Pain Hypersensitivity in Chronic Constriction Injury of Sciatic Nerve Induced-Neuropathy in Mice |
title_short | Curcumin Diglutaric Acid, a Prodrug of Curcumin Reduces Pain Hypersensitivity in Chronic Constriction Injury of Sciatic Nerve Induced-Neuropathy in Mice |
title_sort | curcumin diglutaric acid, a prodrug of curcumin reduces pain hypersensitivity in chronic constriction injury of sciatic nerve induced-neuropathy in mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558758/ https://www.ncbi.nlm.nih.gov/pubmed/32867013 http://dx.doi.org/10.3390/ph13090212 |
work_keys_str_mv | AT limcharoenthanchanok curcumindiglutaricacidaprodrugofcurcuminreducespainhypersensitivityinchronicconstrictioninjuryofsciaticnerveinducedneuropathyinmice AT dasuniwasanapeththawadu curcumindiglutaricacidaprodrugofcurcuminreducespainhypersensitivityinchronicconstrictioninjuryofsciaticnerveinducedneuropathyinmice AT hasriadi curcumindiglutaricacidaprodrugofcurcuminreducespainhypersensitivityinchronicconstrictioninjuryofsciaticnerveinducedneuropathyinmice AT muangnoichawanphat curcumindiglutaricacidaprodrugofcurcuminreducespainhypersensitivityinchronicconstrictioninjuryofsciaticnerveinducedneuropathyinmice AT vajraguptaopa curcumindiglutaricacidaprodrugofcurcuminreducespainhypersensitivityinchronicconstrictioninjuryofsciaticnerveinducedneuropathyinmice AT rojsitthisakpornchai curcumindiglutaricacidaprodrugofcurcuminreducespainhypersensitivityinchronicconstrictioninjuryofsciaticnerveinducedneuropathyinmice AT towiwatpasarapa curcumindiglutaricacidaprodrugofcurcuminreducespainhypersensitivityinchronicconstrictioninjuryofsciaticnerveinducedneuropathyinmice |